Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,568.40
(
0.90%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
95.30
(
-1.25%
)
Bitcoin
71,311.99
(
1.13%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

microcapfun

Send PM Follow Ignore
Followers 6
Posts 560
Boards Moderated 0
Alias Born 03/13/2007

microcapfun

Re: DewDiligence post# 111486

Sunday, 12/26/2010 12:14:59 AM

Sunday, December 26, 2010 12:14:59 AM

Post# of 257275
>>I would not rule out a finding of non-inferiority based on those numbers.<<

I'm not ruling it out. I'm just saying it doesn't look likely - at least if the SPA primary endpoint involves ACR20. Incyte's best bet might be to move the primary endpoint to ACR50 - if the FDA goes along.

micro

Life is an IQ test.

email: microcapfun@yahoo.com

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today